Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease. [electronic resource]
Producer: 20210106ISSN:- 1422-0067
- Animals
- Biomarkers
- Bryophyta -- genetics
- Cells, Cultured
- Energy Metabolism -- drug effects
- Enzyme Replacement Therapy -- methods
- Glycogen Storage Disease Type II -- drug therapy
- Humans
- Mice
- Muscle Cells -- drug effects
- Myoblasts -- drug effects
- Recombinant Proteins -- pharmacology
- alpha-Glucosidases -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.